Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer
Cipla has in-licensed Stempeucel-DFU product for Sales & Marketing in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Stempeucel-DFU
Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer
Under this agreement, Cipla will get the exclusive marketing rights for five years in India for DFU product with Stempeutics…